Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
Healthcare
$8.64 -2.79%
-$0.17 today
- Market cap
- $264.15M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
52W Low $2.57High $26.50
Volume 0.13M
Average 0.04M
Balance Sheet
Inspect the capital base behind the business.
Assets
$12.16M
FY 2025 · Annual
+493.6% YoYLiabilities
$7.48M
FY 2025 · Annual
+235.8% YoYEquity
$4.69M
FY 2025 · Annual
Balance Sheet
USD
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $11.2M |
| Other Current | $235.2K |
| Total Current Assets | $11.5M |
| PP&E (Net) | $67.6K |
| Intangible Assets | $919.9K |
| Other Non-current | $6.2M |
| Total Non-current Assets | $7.2M |
| Total Assets | $18.6M |
Analysis
Selected assets total $18.6M for Latest. The largest visible component is Cash & Equivalents at $11.2M, about 60.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 10, 2026 | |
| S-3 | S-3 filing | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| S-3 | S-3 filing | Nov 9, 2026 |
How much cash does TTRX have?
Turn Therapeutics Inc. (TTRX) reported $5.08M in cash and equivalents in fiscal 2025.
How much debt does TTRX carry?
Turn Therapeutics Inc. (TTRX) reported $80,376.00 of total debt, with net debt of -$5.00M.
Continue the stock analysis
Jump to another research area for this company.